KRON Insider Trading

Insider Ownership Percentage: 24.40%
Insider Buying (Last 12 Months): $2,787,697.16
Insider Selling (Last 12 Months): $0.00

Kronos Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Kronos Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M-$1M$0$1M$2MTotal Insider BuyingTotal Insider Selling

Kronos Bio Share Price & Price History

Current Price: $0.82
Price Change: Price Decrease of -0.007 (-0.85%)
As of 04/1/2025 03:29 PM ET

This chart shows the closing price history over time for KRON up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.82Closing price on 03/31/25:

SEC Filings (Institutional Ownership Changes) for Kronos Bio (NASDAQ:KRON)

64.09% of Kronos Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at KRON by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$1.92Mbought$1.28MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal InflowsTotal Outflows
Kronos Bio logo
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of therapeutics for various cancer and other serious diseases in the United States. Its lead product candidates are KB-0742, an oral cyclin dependent kinase 9 inhibitor for the treatment of MYC-amplified solid tumors, which is in phase 2 clinical trial; and KB-9558, a core oncogenic transcription factor that drives multiple myeloma. The company was incorporated in 2017 and is headquartered in San Mateo, California.
Read More on Kronos Bio

Today's Range

Now: $0.82
Low: $0.81
High: $0.85

50 Day Range

MA: $0.96
Low: $0.82
High: $1.07

52 Week Range

Now: $0.82
Low: $0.69
High: $1.60

Volume

58,451 shs

Average Volume

269,752 shs

Market Capitalization

$49.87 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.79

Who are the company insiders with the largest holdings of Kronos Bio?

Kronos Bio's top insider investors include:
  1. Norbert W Bischofberger (CEO)
  2. Barbara Kosacz (COO)
  3. Yasir B Al-Wakeel (CFO)
  4. Jorge Dimartino (VP)
  5. Christopher Dinsmore (Insider)
  6. Elizabeth A Olek (SVP)
Learn More about top insider investors at Kronos Bio.